{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:07:54Z","timestamp":1793740074551,"version":"4.6.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173452"],"award-info":[{"award-number":["82173452"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of Fujian Province","award":["2020J011014"],"award-info":[{"award-number":["2020J011014"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian provincial health technology project","doi-asserted-by":"crossref","award":["2021CXA011"],"award-info":[{"award-number":["2021CXA011"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11060-025-05132-8","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T07:58:47Z","timestamp":1754985527000},"page":"287-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Collagen type I alpha 1 induces radio-resistance in hypoxic glioblastoma cells by promoting autophagy"],"prefix":"10.1007","volume":"175","author":[{"given":"Miaobin","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaodong","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"6","key":"5132_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"7","key":"5132_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG et al (2014) The epidemiology of glioma in adults: a state of the science review. Neuro-oncol 16(7):896\u2013913. https:\/\/doi.org\/10.1093\/neuonc\/nou087","journal-title":"Neuro-oncol"},{"issue":"suppl4","key":"5132_CR3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2011\u20132015. Neuro-oncol 20(suppl4):iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro-oncol"},{"key":"5132_CR4","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.2147\/IJN.S140462","volume":"13","author":"K Graham","year":"2018","unstructured":"Graham K, Unger E (2018) Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. Int J Nanomed 13:6049\u20136058. https:\/\/doi.org\/10.2147\/IJN.S140462","journal-title":"Int J Nanomed"},{"issue":"4","key":"5132_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","volume":"93","author":"M H\u00f6ckel","year":"2001","unstructured":"H\u00f6ckel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4):266\u2013276. https:\/\/doi.org\/10.1093\/jnci\/93.4.266","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"5132_CR6","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.yexcr.2012.07.017","volume":"318","author":"L Yang","year":"2012","unstructured":"Yang L, Lin C, Wang L, Guo H, Wang X (2012) Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications. Exp Cell Res 318(19):2417\u20132426. https:\/\/doi.org\/10.1016\/j.yexcr.2012.07.017","journal-title":"Exp Cell Res"},{"issue":"4","key":"5132_CR7","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3171\/2015.8.JNS15437","volume":"125","author":"T Siegal","year":"2016","unstructured":"Siegal T, Charbit H, Paldor I et al (2016) Dynamics of Circulating hypoxia-mediated MiRNAs and tumor response in patients with high-grade glioma treated with bevacizumab. J Neurosurg 125(4):1008\u20131015. https:\/\/doi.org\/10.3171\/2015.8.JNS15437","journal-title":"J Neurosurg"},{"issue":"24","key":"5132_CR8","doi-asserted-by":"publisher","first-page":"8177","DOI":"10.1158\/1078-0432.CCR-04-1081","volume":"10","author":"SM Evans","year":"2004","unstructured":"Evans SM, Judy KD, Dunphy I et al (2004) Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10(24):8177\u20138184. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-1081","journal-title":"Clin Cancer Res"},{"key":"5132_CR9","doi-asserted-by":"publisher","unstructured":"D I KE (2016) COX-2 modulates mammary tumor progression in response to collagen density. Breast Cancer Res: BCR 18(1). https:\/\/doi.org\/10.1186\/s13058-016-0695-3","DOI":"10.1186\/s13058-016-0695-3"},{"issue":"18","key":"5132_CR10","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates cancer progression. Cancer Res 79(18):4557\u20134566. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3962","journal-title":"Cancer Res"},{"issue":"1","key":"5132_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.gde.2007.12.006","volume":"18","author":"M Hu","year":"2008","unstructured":"Hu M, Polyak K (2008) Microenvironmental regulation of cancer development. Curr Opin Genet Dev 18(1):27\u201334. https:\/\/doi.org\/10.1016\/j.gde.2007.12.006","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"5132_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1752-0509-4-163","volume":"4","author":"H Dong","year":"2010","unstructured":"Dong H, Luo L, Hong S et al (2010) Integrated analysis of mutations, MiRNA and mRNA expression in glioblastoma. BMC Syst Biol 4(1):163. https:\/\/doi.org\/10.1186\/1752-0509-4-163","journal-title":"BMC Syst Biol"},{"key":"5132_CR13","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.2147\/IJGM.S336421","volume":"14","author":"S Wang","year":"2021","unstructured":"Wang S, Zhou H, Zhang R, Zhang Y (2021) Integrated analysis of mutations, MiRNA and mRNA expression in glioblastoma. Int J Gen Med 14:8281\u20138292. https:\/\/doi.org\/10.2147\/IJGM.S336421","journal-title":"Int J Gen Med"},{"key":"5132_CR14","doi-asserted-by":"publisher","unstructured":"Mustafa DAM, Sieuwerts AM, Zheng PP, Kros JM. Overexpression of colligin 2 in glioma vasculature is associated with overexpression of heat shock factor 2. Gene Regul Syst Biol. 2010;4:GRSB.S4546. https:\/\/doi.org\/10.4137\/GRSB.S4546","DOI":"10.4137\/GRSB.S4546"},{"issue":"3","key":"5132_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jaad.2010.06.020","volume":"65","author":"B Llombart","year":"2011","unstructured":"Llombart B, Monteagudo C, Sanmart\u00edn O et al (2011) Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors. J Am Acad Dermatol 65(3):564\u2013575. https:\/\/doi.org\/10.1016\/j.jaad.2010.06.020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"5132_CR16","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1038\/oncsis.2014.5","volume":"3","author":"A Balbous","year":"2014","unstructured":"Balbous A, Cortes U, Guilloteau K et al (2014) A mesenchymal glioma stem cell profile is related to clinical outcome. Oncogenesis 3(3):e91. https:\/\/doi.org\/10.1038\/oncsis.2014.5","journal-title":"Oncogenesis"},{"key":"5132_CR17","doi-asserted-by":"publisher","unstructured":"Sun S, Wang Y, Wu Y et al (2018) Identification of COL1A1 as an invasion\u2013related gene in malignant Astrocytoma. Int J Oncol Published Online September 21. https:\/\/doi.org\/10.3892\/ijo.2018.4568","DOI":"10.3892\/ijo.2018.4568"},{"key":"5132_CR18","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.12659\/MSM.913602","volume":"25","author":"T Deng","year":"2019","unstructured":"Deng T, Gong YZ, Wang XK et al (2019) Use of genome-scale integrated analysis to identify key genes and potential molecular mechanisms in recurrence of lower-grade brain glioma. Med Sci Monit 25:3716\u20133727. https:\/\/doi.org\/10.12659\/MSM.913602","journal-title":"Med Sci Monit"},{"issue":"1","key":"5132_CR19","doi-asserted-by":"publisher","first-page":"e23541","DOI":"10.1002\/jbt.23541","volume":"38","author":"Q Wang","year":"2024","unstructured":"Wang Q, Wang Z (2024) Serpin family H member 1 and its related collagen gene network are the potential prognostic biomarkers and anticancer targets for glioma. J Biochem Mol Toxicol 38(1):e23541. https:\/\/doi.org\/10.1002\/jbt.23541","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"5132_CR20","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1038\/s41467-022-31340-1","volume":"13","author":"A Comba","year":"2022","unstructured":"Comba A, Faisal SM, Dunn PJ et al (2022) Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression. Nat Commun 13(1):3606. https:\/\/doi.org\/10.1038\/s41467-022-31340-1","journal-title":"Nat Commun"},{"issue":"11","key":"5132_CR21","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.3390\/cancers12113388","volume":"12","author":"KJ Min","year":"2020","unstructured":"Min KJ, Kwon TK (2020) Induction of lysosomal membrane permeabilization is a major event of FTY720-mediated non-apoptotic cell death in human glioma cells. Cancers (Basel) 12(11):3388. https:\/\/doi.org\/10.3390\/cancers12113388","journal-title":"Cancers (Basel)"},{"issue":"11","key":"5132_CR22","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1038\/s41401-022-00917-3","volume":"43","author":"Xjin Zheng","year":"2022","unstructured":"Zheng Xjin, lin Chen W, Yi J et al (2022) Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1\/NRF2 and CBS-regulated ferroptosis. Acta Pharmacol Sin 43(11):2977\u20132992. https:\/\/doi.org\/10.1038\/s41401-022-00917-3","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"5132_CR23","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.3390\/ijms26094398","volume":"26","author":"B Wang","year":"2025","unstructured":"Wang B, Li D, Ilnytskyy Y et al (2025) A positive feedback DNA-PK\/MYT1L-CXCR1-ERK1\/2 proliferative signaling loop in glioblastoma. Int J Mol Sci 26(9):4398. https:\/\/doi.org\/10.3390\/ijms26094398","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5132_CR24","doi-asserted-by":"publisher","first-page":"e92908","DOI":"10.1371\/journal.pone.0092908","volume":"9","author":"C Zhao","year":"2014","unstructured":"Zhao C, Wu N, Deng F et al (2014) Adenovirus-mediated gene transfer in mesenchymal stem cells can be significantly enhanced by the cationic polymer polybrene. PLoS ONE 9(3):e92908. https:\/\/doi.org\/10.1371\/journal.pone.0092908","journal-title":"PLoS ONE"},{"issue":"1","key":"5132_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3892\/ol.2020.12274","volume":"21","author":"Y Liu","year":"2021","unstructured":"Liu Y, Ju Y, Liu J, Chen Y, Huo X, Liu L (2021) Inhibition of proliferation and migration and induction of apoptosis in glioma cells by Silencing TLR4 expression levels via RNA interference. Oncol Lett 21(1):13. https:\/\/doi.org\/10.3892\/ol.2020.12274","journal-title":"Oncol Lett"},{"key":"5132_CR26","unstructured":"Technology CS (2025) Western blot (WB) resource center. Cell Signaling Technology. Accessed June 11. https:\/\/www.cellsignal.com\/applications\/western-blot-immunoblot"},{"issue":"1","key":"5132_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-020-00916-7","volume":"8","author":"Y Matsumoto","year":"2020","unstructured":"Matsumoto Y, Ichikawa T, Kurozumi K et al (2020) Annexin A2\u2013STAT3\u2013Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma. Acta Neuropathol Commun 8(1):42. https:\/\/doi.org\/10.1186\/s40478-020-00916-7","journal-title":"Acta Neuropathol Commun"},{"key":"5132_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fphys.2017.00365","volume":"8","author":"E Mata-Greenwood","year":"2017","unstructured":"Mata-Greenwood E, Goyal D, Goyal R (2017) Comparative and experimental studies on the genes altered by chronic hypoxia in human brain microendothelial cells. Front Physiol 8:365. https:\/\/doi.org\/10.3389\/fphys.2017.00365","journal-title":"Front Physiol"},{"issue":"6","key":"5132_CR29","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1200\/JCO.2009.24.1893","volume":"28","author":"AM Evens","year":"2010","unstructured":"Evens AM, Sehn LH, Farinha P et al (2010) Hypoxia-inducible factor-1 \u03b1 expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 28(6):1017\u20131024. https:\/\/doi.org\/10.1200\/JCO.2009.24.1893","journal-title":"J Clin Oncol"},{"issue":"8","key":"5132_CR30","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/hr.2012.32","volume":"35","author":"TA Ramirez","year":"2012","unstructured":"Ramirez TA, Jourdan-Le Saux C, Joy A et al (2012) Chronic and intermittent hypoxia differentially regulate left ventricular inflammatory and extracellular matrix responses. Hypertens Res 35(8):811\u2013818. https:\/\/doi.org\/10.1038\/hr.2012.32","journal-title":"Hypertens Res"},{"issue":"7","key":"5132_CR31","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00432-017-2381-y","volume":"143","author":"U Oleksiewicz","year":"2017","unstructured":"Oleksiewicz U, Liloglou T, Tasopoulou KM et al (2017) COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer. J Cancer Res Clin Oncol 143(7):1133\u20131141. https:\/\/doi.org\/10.1007\/s00432-017-2381-y","journal-title":"J Cancer Res Clin Oncol"},{"issue":"Suppl 5","key":"5132_CR32","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","volume":"14","author":"TA Dolecek","year":"2012","unstructured":"Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the united States in 2005\u20132009. Neuro-oncol 14(Suppl 5):v1\u201349. https:\/\/doi.org\/10.1093\/neuonc\/nos218","journal-title":"Neuro-oncol"},{"issue":"6","key":"5132_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1634\/theoncologist.7-6-492","volume":"7","author":"LB Harrison","year":"2002","unstructured":"Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D (2002) Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 7(6):492\u2013508. https:\/\/doi.org\/10.1634\/theoncologist.7-6-492","journal-title":"Oncologist"},{"issue":"4","key":"5132_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc3007","volume":"11","author":"AC Begg","year":"2011","unstructured":"Begg AC, Stewart FA, Vens C (2011) Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer 11(4):239\u2013253. https:\/\/doi.org\/10.1038\/nrc3007","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5132_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C et al (2019) Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer 18(1):157. https:\/\/doi.org\/10.1186\/s12943-019-1089-9","journal-title":"Mol Cancer"},{"key":"5132_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz B, de la Puente P, Azab F, Azab AK (2015) The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (auckl NZ) 3:83\u201392. https:\/\/doi.org\/10.2147\/HP.S93413","journal-title":"Hypoxia (auckl NZ)"},{"issue":"7","key":"5132_CR37","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/neuonc\/now258","volume":"19","author":"N Colwell","year":"2017","unstructured":"Colwell N, Larion M, Giles AJ et al (2017) Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neuro-oncol 19(7):887\u2013896. https:\/\/doi.org\/10.1093\/neuonc\/now258","journal-title":"Neuro-oncol"},{"issue":"3","key":"5132_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/1874-470210902030263","volume":"2","author":"L Oliver","year":"2009","unstructured":"Oliver L, Olivier C, Marhuenda F, Campone M, Vallette F (2009) Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Curr Mol Pharmacol 2(3):263\u2013284. https:\/\/doi.org\/10.2174\/1874467210902030263","journal-title":"Curr Mol Pharmacol"},{"issue":"5","key":"5132_CR39","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/jcp.2007.050666","volume":"61","author":"CY Chai","year":"2008","unstructured":"Chai CY, Chen WT, Hung WC et al (2008) Hypoxia-inducible factor-1\u03b1 expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. J Clin Pathol 61(5):658\u2013664. https:\/\/doi.org\/10.1136\/jcp.2007.050666","journal-title":"J Clin Pathol"},{"issue":"26","key":"5132_CR40","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM197912273012606","volume":"301","author":"JD Chapman","year":"1979","unstructured":"Chapman JD (1979) Hypoxic sensitizers\u2013implications for radiation therapy. N Engl J Med 301(26):1429\u20131432. https:\/\/doi.org\/10.1056\/NEJM197912273012606","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"5132_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/sj.bjc.6690345","volume":"80","author":"K Kohshi","year":"1999","unstructured":"Kohshi K, Kinoshita Y, Imada H et al (1999) Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas. Br J Cancer 80(1\u20132):236\u2013241. https:\/\/doi.org\/10.1038\/sj.bjc.6690345","journal-title":"Br J Cancer"},{"issue":"5","key":"5132_CR42","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ijrobp.2009.12.010","volume":"76","author":"MC McGee","year":"2010","unstructured":"McGee MC, Hamner JB, Williams RF et al (2010) Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation. Int J Radiat Oncol Biol Phys 76(5):1537\u20131545. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.12.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"5132_CR43","doi-asserted-by":"publisher","first-page":"e111199","DOI":"10.1371\/journal.pone.0111199","volume":"9","author":"RH Clarke","year":"2014","unstructured":"Clarke RH, Moosa S, Anzivino M et al (2014) Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia. PLoS ONE 9(10):e111199. https:\/\/doi.org\/10.1371\/journal.pone.0111199","journal-title":"PLoS ONE"},{"issue":"4","key":"5132_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.15407\/ubj86.04.079","volume":"86","author":"OH Kyiv, Minchenko","year":"2014","unstructured":"Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv, Minchenko OH (2014) Effect of hypoxia on the expression of CCN2, PLAU, PLAUR, SLURP1, PLAT and ITGB1 genes in ERN1 knockdown U87 glioma cells. Ukr Biochem J 86(4):79\u201389. https:\/\/doi.org\/10.15407\/ubj86.04.079","journal-title":"Ukr Biochem J"},{"issue":"17","key":"5132_CR45","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/jnci\/93.17.1337","volume":"93","author":"A Lal","year":"2001","unstructured":"Lal A, Peters H, St. Croix B et al (2001) Transcriptional response to hypoxia in human tumors. JNCI J Natl Cancer Inst 93(17):1337\u20131343. https:\/\/doi.org\/10.1093\/jnci\/93.17.1337","journal-title":"JNCI J Natl Cancer Inst"},{"key":"5132_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2017.11.033","volume":"416","author":"Y Li","year":"2018","unstructured":"Li Y, He ZC, Zhang XN et al (2018) Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1. Cancer Lett 416:66\u201374. https:\/\/doi.org\/10.1016\/j.canlet.2017.11.033","journal-title":"Cancer Lett"},{"issue":"12","key":"5132_CR47","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/pmic.201300554","volume":"14","author":"JH Yoon","year":"2014","unstructured":"Yoon JH, Kim J, Kim KL et al (2014) Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia\u2010dependent migration factors. Proteomics 14(12):1494\u20131502. https:\/\/doi.org\/10.1002\/pmic.201300554","journal-title":"Proteomics"},{"issue":"8","key":"5132_CR48","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.18632\/oncotarget.3467","volume":"6","author":"K Frei","year":"2015","unstructured":"Frei K, Gramatzki D, Tritschler I et al (2015) Transforming growth factor-\u03b2 pathway activity in glioblastoma. Oncotarget 6(8):5963\u20135977. https:\/\/doi.org\/10.18632\/oncotarget.3467","journal-title":"Oncotarget"},{"issue":"9","key":"5132_CR49","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1111\/jcmm.14507","volume":"23","author":"Y Gao","year":"2019","unstructured":"Gao Y, Zhang E, Liu B et al (2019) Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma. J Cell Mol Med 23(9):6228\u20136237. https:\/\/doi.org\/10.1111\/jcmm.14507","journal-title":"J Cell Mol Med"},{"issue":"6","key":"5132_CR50","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/cancers11060786","volume":"11","author":"HP Ma","year":"2019","unstructured":"Ma HP, Chang HL, Bamodu OA et al (2019) Collagen 1A1 (COL1A1) is a reliable biomarker and putative therapeutic target for hepatocellular carcinogenesis and metastasis. Cancers 11(6):786. https:\/\/doi.org\/10.3390\/cancers11060786","journal-title":"Cancers"},{"key":"5132_CR56","unstructured":"Liu J, Shen JX, Wu HT et al (2018) Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov Med 25(139):211\u201323."},{"key":"5132_CR57","doi-asserted-by":"publisher","unstructured":"Li A qing, Si J min, Shang Y, Gan L hong, Guo L, Zhou T hua et al (2010) construction of COL1A1 short hairpin RNA vector and its effect on cell proliferation and migration of gastric cancer cells. J Zhejiang Univ (Medical Sci) 39(3):257\u2013263. https:\/\/doi.org\/10.3785\/j.issn.1008-9292.2010.03.008","DOI":"10.3785\/j.issn.1008-9292.2010.03.008"},{"issue":"1","key":"5132_CR53","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3892\/ol.2015.3929","volume":"11","author":"H Sun","year":"2016","unstructured":"Sun H (2016) Identification of key genes associated with gastric cancer based on DNA microarray data. Oncol Lett 11(1):525\u2013530. https:\/\/doi.org\/10.3892\/ol.2015.3929","journal-title":"Oncol Lett"},{"issue":"1","key":"5132_CR51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12957-016-1056-5","volume":"14","author":"J Li","year":"2016","unstructured":"Li J, Ding Y, Li A (2016) Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer. World J Surg Oncol 14(1):297. https:\/\/doi.org\/10.1186\/s12957-016-1056-5","journal-title":"World J Surg Oncol"},{"issue":"1","key":"5132_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-2407-14-108","volume":"14","author":"M Hayashi","year":"2014","unstructured":"Hayashi M, Nomoto S, Hishida M et al (2014) Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma. BMC Cancer 14(1):108. https:\/\/doi.org\/10.1186\/1471-2407-14-108","journal-title":"BMC Cancer"},{"key":"5132_CR54","doi-asserted-by":"publisher","unstructured":"Ren J, Da J, Hu N. Identification of COL1A1 associated with immune infiltration in brain lower grade glioma. Batra SK, ed. PLOS One. 2022;17(7):e0269533. https:\/\/doi.org\/10.1371\/journal.pone.0269533","DOI":"10.1371\/journal.pone.0269533"},{"issue":"1","key":"5132_CR55","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12935-021-01982-0","volume":"21","author":"W Yin","year":"2021","unstructured":"Yin W, Zhu H, Tan J et al (2021) Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma. Cancer Cell Int 21(1):276. https:\/\/doi.org\/10.1186\/s12935-021-01982-0","journal-title":"Cancer Cell Int"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05132-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:03:53Z","timestamp":1757379833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05132-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5132"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05132-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval of the research protocol by an Institutional Reviewer Board: N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"TCGA and GEO belong to public databases. The patients involved in the database have signed ethical approval. Users can download relevant data for free for research and publish relevant articles. Our study is based on open source data, so there are no ethical issues and other conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the registration No. of the study\/trial"}},{"value":"N\/A.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}